Entering text into the input field will update the search result below

Autolus Therapeutics (AUTL) CEO Christian Itin on Q4 2019 Results - Earnings Call Transcript

Mar. 03, 2020 2:38 PM ETAutolus Therapeutics plc (AUTL)
SA Transcripts profile picture
SA Transcripts

Autolus Therapeutics (NASDAQ:AUTL) Q4 2019 Earnings Conference Call March 3, 2020 8:30 AM ET

Company Participants

Lucinda Crabtree - VP, IR

Christian Itin - Chairman & CEO

Andrew Oakley - CFO & SVP

Conference Call Participants

Aaron Welch - H.C. Wainwright & Co.

Chad Messer - Needham & Company

Biren Amin - Jefferies

Matthew Phipps - William Blair & Company

Graig Suvannavejh - Goldman Sachs Group

Nicholas Abbott - Wells Fargo Securities


Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics FY 2019 Q4 2019 Financial Results Conference Call. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dr. Lucinda Crabtree, Vice President of Investor Relations. Please go ahead.

Lucinda Crabtree

Thank you, Kevin. Good morning or good afternoon, everyone, and thank you for taking part in today's call on the financial results and operational highlights for the full year 2019. I am Lucinda Crabtree, Vice President of Investor Relations. With me today are Dr. Christian Itin, our Chairman and Chief Executive Officer; and Andrew Oakley, our Chief Financial Officer.

Before we begin, I would like to remind you that during this call, we will be making forward-looking statements. All statements other than the statements of historical facts contained in this presentation are forward-looking statements. Our actual results, performance or achievements may be materially different from those expressed or implied by the forward-looking statements. For a discussion of the risks and uncertainties relating to our business and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, please see the section titled Risk Factors in our annual report on Form 20-F filed on March 3, 2020 as well as discussions of potential risks, uncertainties and other important factors in our other periodic filings with the SEC.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.